Literature DB >> 4171454

Plasma heme-binding in patients with hemolytic disorders.

D A Sears.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171454

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  9 in total

1.  [The decrease of circulating serum hemopexins in non-hemolytic diseases].

Authors:  H J Braun; F W Aly
Journal:  Klin Wochenschr       Date:  1970-06-15

2.  [Clinical significance of quantitative serum hemopexin assessment as compared with that of haptoglobin].

Authors:  H J Braun; F W Aly
Journal:  Klin Wochenschr       Date:  1971-04-15

3.  [Properties, function and serum concentration of human hemopexin].

Authors:  H J Braun
Journal:  Klin Wochenschr       Date:  1971-04-15

4.  The effect of plasma and transferrin on the hemin inhibition of iron uptake by reticulocytes.

Authors:  P Ponka; J Neuwirt
Journal:  Experientia       Date:  1972-02-15

5.  Iron compounds and resistance to infection. Further experiments with Clostridium welchii type A in vivo and in vitro.

Authors:  H J Rogers; J J Bullen; G H Cushnie
Journal:  Immunology       Date:  1970-10       Impact factor: 7.397

6.  Identification of oxidative modifications of hemopexin and their predicted physiological relevance.

Authors:  Peter Hahl; Rachel Hunt; Edward S Bjes; Andrew Skaff; Andrew Keightley; Ann Smith
Journal:  J Biol Chem       Date:  2017-06-08       Impact factor: 5.157

7.  Disposal of plasma heme in normal man and patients with intravascular hemolysis.

Authors:  D A Sears
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

8.  Sites of formation of the serum proteins transferrin and hemopexin.

Authors:  G J Thorbecke; H H Liem; S Knight; K Cox; U Muller-Eberhard
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

Review 9.  Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.

Authors:  Ann Smith; Russell J McCulloh
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.